Delivery Order SPE2DB20D9223-SPE2DB23FV81J

Award Date 8/15/23
Potential Completion Date 9/6/23
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,943.10 firm fixed-price delivery order is for the provision of 4,567,731,884 units of NEXPLANON 68 MG IMPLANTS. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,293.80, is a delivery order issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA. The contract is for the delivery of 4,566,706,862 units of NEXPLANON 68 MG IMPLANTS, a specialized pharmaceutical product. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $54,699.20 firm fixed-price delivery order is for the supply of 4,562,278,510 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which runs through December 31,...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order valued at $3,074.80 for the provision of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which has a total potential...
This federal contract award with ID SPE2DB20D9332|SPE2DB23FV3C7 was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,093.50 firm fixed-price delivery order is for the procurement of 4,561,680,382 units of NEXPLANON 68 MG IMPLANTS, with a completion date of August 17, 2023. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,204.88 contract is for the delivery of 4,562,145,573 units of NEXPLANON 68 MG IMPLANTS, with a performance period ending on September 29, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,720.35 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS and has an ultimate completion date of August 15, 2024. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $35,734.50, is for the delivery of 4,565,977,607 units of the NEXPLANON 68 MG IMPLANTS contraceptive device. The contract is a firm fixed-price delivery order and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award...
This federal contract award, valued at $1,388.64, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for 4,567,571,204 units of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The contract is a firm fixed-price award with an ultimate completion date of April 1, 2025. DMS Pharmaceutical Group Inc. also holds a significant single-award Indefinite...
This federal contract award, valued at $4,288.14, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, with a performance period ending on September 26, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the...
  • SPE2DB20D9223
    Indefinite Delivery Contract
  • SPE2DB20D9223-SPE2DB23FV81J
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,837.40 firm fixed-price delivery order is for the supply of 4,561,965,899 units of NEXPLANON 68 MG IMPLANTS, with a final completion date of September 6, 2023.

DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This specific delivery order is not associated with any set-aside designation, enabling DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this direct federal award. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense.

Generated 2/27/25, 11:52 AM